openPR Logo
Press release

Viral Vector Manufacturing Market is expected to grow at a CAGR of 22.65% by 2023

01-13-2022 08:46 AM CET | Health & Medicine

Press release from: market research future

Viral Vector Manufacturing Market is expected to grow at a CAGR

Overview:
Acknowledging the exponential accruals, the market is witnessing currently, Market Research Future (MRFR) in its recently published study report asserts that the global viral vector manufacturing market will garner a value of USD 319 MN by 2023, registering a whopping CAGR of approx. 22.65% throughout the forecast period (2018-2023).

Viral vector manufacturing refers to the production of a carrier called a vector which is genetically engineered to deliver the gene because they can deliver the new gene by infecting the cell. Considered as a drug substance, viral vectors are used in gene therapy and vaccinology (vaccines). In the case of cell therapies, the scrutiny for testing for adventitious agents is high.
Viruses that are often used as vectors include retroviruses that integrate their genetic material including the new gene in the human cell, and adenoviruses, that introduce their DNA into the nucleus of the cell without letting the DNA to integrate into a chromosome. These viruses are modified so they can't cause disease when used in people.

Gene therapy has seen various clinical advancement, and along with it, the viral vector manufacturing market is growing pervasively. Gene therapy is one of the most preferred treatment options for a number of chronic diseases. Over the past few years, the viral vector manufacturing market is growing rapidly mainly due to the growing prevalence of devastating neurodegenerative diseases including Parkinson’s, Alzheimer’s, and ALS.

Request Free Sample Copy at: https://www.marketresearchfuture.com/sample_request/6890

The increasing number of clinical trials and the growing necessity for an effective mode of disease treatment are some of the factors fostering the growth of the market. Additional factors having a synergistic effect on the growth of the viral vector manufacturing market include the increasing number of technological advancements, a growing number of ambulatory services, and government initiatives.

On the flip side, factors such as the high cost of gene therapies and possible mutagenesis alongside the strict government regulation and time-consuming approval process are expected to impede market growth.
Global Viral Vector Manufacturing Market – Segmentations
The MRFR analysis is segmented into five key dynamics for enhanced understanding.
By Type: Retroviral Vectors, Adeno-Associated Viral Vectors, and Adenoviral Vectors among others.
By Disease: Cancer, Genetic Disorders and Infectious Diseases among others.
By Application: Gene Therapy and Vaccinology among others.

By End-user : Pharmaceutical Companies, Biotechnology Companies, and Research Institutes, among others.
By Regions: Asia Pacific, North America, Europe, and the Rest-of-the-World.
Global Viral Vector Manufacturing Market - Regional Analysis
The North American Region heading with the growing prevalence of autoimmune and chronic diseases, accounts for the leading market for viral vector manufacturing, globally. Moreover, technological advancements in the manufacturing of these vectors is a key force driving the growth of this market.

Additionally, favorable reimbursement policies and the presence of well-developed healthcare infrastructure, and increasing geriatric population are some of the key driving forces contributing to the growth of the regional market.
The U.S., backed by a large number of patients suffering from Alzheimer’s and Parkinson's diseases, majorly contributes to an increase in the demand for viral vectors in the region. Moreover, factors such as the high healthcare expenditures alongside the availability of viruses required for the production of these vectors and technological expertise drive the growth of the regional market.
The European region, led by the well-established R&D sector accounts for the second-largest market for viral vector manufacturing. Besides, factors such as the availability of funds for research and increasing healthcare expenditures drive the regional market. Moreover, the increase in occurrences of chronic diseases has led to the rise in the market growth in the region. Also, the presence of a developed healthcare sector and the resurging economy in the region foster the growth of the viral vector manufacturing market in Europe.
The viral vector manufacturing market in the Asia Pacific region is emerging as a promising market owing to the huge patient population suffering from diseases such as Parkinson’s, Alzheimer’s, and ALS.

Moreover, continuously growing healthcare sector led by the rapid economic growth in the APAC that is increasing the per capita healthcare expenses is a dominant driving force behind the growth of the regional market. Recent economic data suggests that China along with Southeast Asia is expected to join the ranks of the deep-pocketed Asian economies such as Taiwan and Korea.

China, owing to the presence of a huge geriatric population leads the viral vector manufacturing market in the APAC. Whereas, India due to the vast population base, rapidly changing economy, and the increasing number of manufacturers of these vectors, accounts for the second largest market in the region.

Whereas, the Middle East & Africa (MEA)region has the least market share due to the lack of awareness and low healthcare expenditures. The viral vector manufacturing market in the MEA region will exhibit moderate growth during the corresponding period.

Global Viral Vector Manufacturing Market - Competitive Analysis
The structure of the viral vector manufacturing market is changing due to the acquisition of local manufactures by multinational companies. Due to the increasing competition in the market, multination companies are using the strategy of acquisition, which has increased the profit of the company as well as significantly reduced the competition.

Major Players:
Key players leading the global viral vector manufacturing market include Sanofi, Lonza, FUJIFILM Diosynth Biotechnologies U.S.A., Inc., Merck KGaA, General Electric Company, uniQure N.V., Oxford BioMedica, Spark Therapeutics, Inc., FinVector Vision Therapies, Cobra Biologics, Brammer Bio, Cell and Gene Therapy Catapult, REGENXBIO Inc., and Kaneka Eurogentec S.A. among others.

Industry/Innovation/Related News:
February 04, 2019 ---- SIRION BIOTECH GmbH (Germany), a leading global company providing the most comprehensive viral vector production and customization services announced its expansion in North America, hosting a Bavarian-themed grand opening event at the Forsyth Institute, the US to meet and mingle with the Cambridge gene therapy scene.

Browse Detailed TOC with COVID-19 Impact Analysis at: https://www.marketresearchfuture.com/reports/viral-vector-manufacturing-market-6890

During the event, SIRION also mentioned that Gene therapy has seen robust clinical advancement and Sirion is becoming a preferred partner in this growing sector.
January 28, 2019 ---- SIRION BIOTECH GmbH (Germany), a leading global company providing the most comprehensive viral vector production and customization services announced its partnership with Denali Therapeutics to support local gene therapy research and clinical development with viral vector contract manufacturing. The licensing agreement is about developing a new generation of adeno-associated virus (AAV) vectors.

This ground-breaking licensing agreement (collaboration) is expected to help Denali Therapeutics to increase the availability of protein therapeutics and to quickly enter clinical trials with safe, efficient, and scalable therapeutic candidates.

While, this partnership with Denali, will help Sirion to send its CNS-directed AAV-based gene therapies to the market in the fastest way possible, providing advanced treatment options to millions of patients, worldwide.

Browse Related Reports at:
https://www.marketresearchfuture.com/reports/healthcare-personal-protection-equipment-market-9594

https://www.marketresearchfuture.com/reports/infrared-thermometer-market-9771

https://www.marketresearchfuture.com/reports/hydroxychloroquine-market-10082

Contact us:
Market Research Future (part of Wantstats Research and Media Private Limited),
99 Hudson Street, 5Th Floor,
New York, New York 10013
United States of America
+1 646 845 9312
Email: sales@marketresearchfuture.com

About Market Research Future:
At Market Research Future (MRFR), we enable our customers to unravel the complexity of various industries through our Cooked Research Report (CRR), Half-Cooked Research Reports (HCRR), & Consulting Services. MRFR team have supreme objective to provide the optimum quality market research and intelligence services to our clients.

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Viral Vector Manufacturing Market is expected to grow at a CAGR of 22.65% by 2023 here

News-ID: 2525770 • Views: 180

More Releases from market research future

Corporate Wellness Market Research Report, Industry Growth, Business Share, Size …
Market Highlights: The Global Corporate Wellness Market will reach value of USD 93.0 Billion in 2028 and is projected to grow at a CAGR of 7.0% over the forecast period. Corporate wellness programs are health promotion activities designed & conducted by corporate employers to support employees to understand their health risks, pursue healthy behavior at the workplace, and decrease the expenditure on healthcare. Currently, these programs are increasingly conducted by corporates
Facial Injectors Market Research Report, Industry Growth, Business Share, Size, …
Facial Injectors Market Information By Type (Dermal Fillers/Injectable Implants, Hyaluronic Acid, Synthetic Fillers, Collagen Fillers, Anti-Aging/Anti-Wrinkle Injections, Botulinum Toxin A, Poly-L-Lactic Acid (PLLA) Microparticles), By Application (Facial Line Correction Treatment, Face-Lift, Lip Treatments), By End-User (Dermatology Clinics & Cosmetic Centers, Hospitals), By Region (Americas, Europe, Asia Pacific and The Middle East & Africa) – till 2027 Market Scenario Market Research Future (MRFR) speculates that the Global Facial Injectors Market is predicted to
Healthcare Cold Chain Logistics Market Global Demand, Stock, Strategy, Size, Bus …
Healthcare Cold Chain Logistics Market Information by Product type (Biopharmaceuticals, Vaccines, Clinical Trial Materials and Others), Services (Storage, Transportation, Packaging and Others), Storage Techniques (Electrical refrigeration, Dry Ice, Gel Packs, Liquid nitrogen and Others), By Region (North America, Europe, Asia Pacific, The Middle East & Africa (MEA) and Latin America) – Global Forecast by 2027 Healthcare Cold Chain Logistics Market – Overview The progress in the pharmaceutical sector has amplified the reliance
Ophthalmic Drugs Market Research Report, Industry Growth, Business Share, Size, …
“Global Ophthalmic Drugs Market” Report of Market Research Future (MRFR)’s Explores Scope of the Study as Research Objective, Assumptions and Limitations in-depth. The report gives Market Dynamics by Major Drivers, Restraints, Opportunities and Challenges. Market Scenario A number of factors such as rising prevalence of eye diseases, growing awareness, huge research funding in ophthalmology, unmet medical needs, rising competition among market players, improving regulatory framework, aging population, and increasing government assistance, are

All 5 Releases


More Releases for Vector

Global Vector Network Analyzer Market Research Report - Forecast to 2023
Vector Network Analyzer Market 2020 comprises a detailed survey of the Vector Network Analyzer Market size, share, trends, extension, consumption, and share, segments, application and Forecast 2025. Global "Vector Network Analyzer" Market 2020-2025 Report contains all demographic as well as analytical data regarding market review, growth, demand, and budget analysis. The report mainly highlights the significant trends of the Vector Network Analyzer market in terms of thriving companies, business methods, product
Cigarillos Market Analysis 2025| Altria| British American Tobacco| Vector Group
HTF MI released a new market study on Global Cigarillos Market with 100+ market data Tables, Pie Chat, Graphs & Figures spread through Pages and easy to understand detailed analysis. At present, the market is developing its presence. The Research report presents a complete assessment of the Market and contains a future trend, current growth factors, attentive opinions, facts, and industry validated market data. The research study provides estimates for
Vector Network Analyzer Market Recent Enhancements and Global Briefing 2018
Global Vector Network Analyzer Market Research Report 2018 This report studies Vector Network Analyzer Market in Worldwide, especially in North America, China, Europe, Southeast Asia, Japan and India, with production, revenue, consumption, import and export in these regions, from 2013 to 2017, and forecast to 2025. This report includes the estimation of market size for value (million USD) and volume (Unit). Both top-down and bottom-up approaches have been used to estimate
Global Vector Signal Generator Market 2018 - Anritsu, Fortive, Keysight Technolo …
Apex Market Reports, recently published a detailed market research study focused on the “Vector Signal Generator Market” across the global, regional and country level. The report provides 360° analysis of “Vector Signal Generator Market” from view of manufacturers, regions, product types and end industries. The research report analyses and provides the historical data along with current performance of the global PP Pipe industry, and estimates the future trend of Vector
Vector Network Analyzer Market Estimated to Flourish at by 2025
A radio frequency analyzer or a network analyzer is the device for analyzing the electric networks parameters. The device is the combination of hardware and software. A recent report published by Persistence Market Research reveals various factors influencing the growth of the market as well as numerous trends driving growth of the market. Number of parameter associated with the market were considered while forecasting dynamics of the market, and based
Global Viral Vector Development Service Market
The Viral Vector Development Service Market report provides in-depth analysis of parent market trends, macro-economic indicators and governing factors along with market attractiveness as per segments. The report also maps the qualitative impact of various market factors on market segments and geographies. Owing to the immense potential of gene therapy, the use of viral vectors has increased significantly over the years. In order to fulfill the current need of viral vectors,